L26/P-679 Clinical and reproductive impact of the updated antral follicle count threshold in infertile women with Polycystic Ovary Syndrome
Human Reproduction · 01.07.2026 · 41 (Supplement_1)
DOI: 10.1093/humrep/deag083.1009 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von H. Badran und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Study question Does applying the updated AFC improve the clinical classification of infertile women with PCOS, and how does it relate to ovulation induction outcomes? Summary answer Updated AFC threshold refines sonographic classification of PCOS but does not improve ovulation or pregnancy outcomes, while excluding a subgroup with unfavourable metabolic, hormonal profiles. What is known already The 2018 international evidence-based guideline for PCOS increased the AFC cutoff from ≥12 to ≥ 20 follicles per ovary in response to advances in ultrasound technology. The clinical and reproductive implications of this higher threshold remain uncertain. Study design, size, duration Prospective case–control study conducted over 18 months, including 150 infertile women aged 20–40 years. Participants/materials, setting, methods Participants were classified into three groups: infertile non-PCOS controls, PCOS diagnosed by Rotterdam 2003 criteria (AFC ≥12), and PCOS diagnosed according to the 2018 guideline (AFC ≥20). All women underwent standardised transvaginal ultrasonography using high-frequency probes, hormonal and metabolic assessment, and ovulation induction with letrozole (2.5–7.5 mg/day) for up to three cycles. Ovulation and pregnancy outcomes were compared between groups. Main results and the role of chance Applying the updated AFC threshold significantly reduced the number of women diagnosed with PCOS. Women fulfilling the 2018 criteria had significantly higher AFC, ovarian volume, AMH, and LH levels compared with controls (p < 0.05). Ovulation rates were significantly lower in PCOS groups compared with controls (p < 0.05), with no significant difference between women diagnosed by the Rotterdam 2003 and 2018 criteria. Pregnancy rates did not differ significantly between groups (p > 0.05). Notably, women excluded by the updated AFC cutoff demonstrated significantly less favorable metabolic and hormonal profiles compared with controls (p < 0.05). Limitations, reasons for caution Single-center design and operator-dependent AFC assessment may limit generalisability. Wider implications of the findings While the updated AFC threshold improves sonographic classification, it does not enhance reproductive outcomes and may overlook women at increased metabolic risk. Comprehensive clinical and biochemical assessment remains essential when managing infertility in women with PCOS. Trial registration number No
Zitieren
APA
Badran, H., Elsayed, M., Tawwab, A. A. E., & Mojahed, E. (2026). L26/P-679 Clinical and reproductive impact of the updated antral follicle count threshold in infertile women with Polycystic Ovary Syndrome. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.1009
Vancouver
Badran H, Elsayed M, Tawwab AAE, Mojahed E. L26/P-679 Clinical and reproductive impact of the updated antral follicle count threshold in infertile women with Polycystic Ovary Syndrome. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.1009
BibTeX
@article{Badran2026,
author = {Badran, H. and Elsayed, M. and Tawwab, A. Abd El and Mojahed, E.},
title = {L26/P-679 Clinical and reproductive impact of the updated antral follicle count threshold in infertile women with Polycystic Ovary Syndrome},
journal = {Human Reproduction},
year = {2026},
volume = {41},
number = {Supplement_1},
doi = {10.1093/humrep/deag083.1009}
}
EUVIMED